From the publishers of The New England Journal of Medicine
Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.
Some content may require paid access to the site. Subscribe or
purchase a seven-day site pass for the full text of
all our clinical perspectives on medical journal articles, guidelines, and news.
FDA advises that patients who use bisphosphonates for osteoporosis can continue to do so.
Tranexamic acid has been approved for treatment of women with menorrhagia.
Diagnosis of early breast and prostate cancer has risen with screening, but the number of advanced cancers has not fallen.
FDA approves the LNG-IUS for treating patients with menorrhagia.
One-dose formulation is approved; two-dose formulation goes generic.
Some women feel financial pressure to defer checkups and curtail use of prescription medications, including contraceptives.
The FDA has expanded approval of nonprescription Plan B access to include 17-year-olds.
In 2006, U.S. teen birth rates increased for the first time since 1991.
An AP poll found that 67% of adults support access to contraception in public schools.
The FDA has approved a second SERM for breast cancer chemoprophylaxis.